Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing

 
• By Sue Sutter

Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.

Supply chain
Drug shortages, foreign manufacturing and supply chain vulnerability were a common, intertwined thread throughout the appropriations subcommittee hearing. • Source: Shutterstock

More from Distribution/Supply Chain

More from Compliance